249 related articles for article (PubMed ID: 37599803)
21. Recent developments in veterinary vaccinology.
Shams H
Vet J; 2005 Nov; 170(3):289-99. PubMed ID: 16266843
[TBL] [Abstract][Full Text] [Related]
22. Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.
Poland GA; Kennedy RB; McKinney BA; Ovsyannikova IG; Lambert ND; Jacobson RM; Oberg AL
Semin Immunol; 2013 Apr; 25(2):89-103. PubMed ID: 23755893
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics.
Poland GA; Ovsyannikova IG; Jacobson RM; Smith DI
Clin Pharmacol Ther; 2007 Dec; 82(6):653-64. PubMed ID: 17971814
[TBL] [Abstract][Full Text] [Related]
24. [Reverse vaccinology: strategy against emerging pathogens].
Monterrubio-López GP; Delgadillo-Gutiérrez K
Rev Med Inst Mex Seguro Soc; 2021 Aug; 59(3):233-241. PubMed ID: 34370422
[TBL] [Abstract][Full Text] [Related]
25. Beyond epitopes: future and application of computational vaccinology.
Söllner J
Hum Vaccin; 2011 Jul; 7(7):795-7. PubMed ID: 21445008
[TBL] [Abstract][Full Text] [Related]
26. Biosecurity risks associated with vaccine platform technologies.
Sandbrink JB; Koblentz GD
Vaccine; 2022 Apr; 40(17):2514-2523. PubMed ID: 33640142
[TBL] [Abstract][Full Text] [Related]
27. Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?
Poland GA; Kennedy RB; Ovsyannikova IG
PLoS Pathog; 2011 Dec; 7(12):e1002344. PubMed ID: 22241978
[TBL] [Abstract][Full Text] [Related]
28. Virus-like particle-based vaccines for animal viral infections.
Crisci E; Bárcena J; Montoya M
Inmunologia; 2013; 32(3):102-116. PubMed ID: 32287712
[TBL] [Abstract][Full Text] [Related]
29. Current Challenges in Vaccinology.
Kennedy RB; Ovsyannikova IG; Palese P; Poland GA
Front Immunol; 2020; 11():1181. PubMed ID: 32670279
[TBL] [Abstract][Full Text] [Related]
30. Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae.
O'Ryan M; Vidal R; del Canto F; Salazar JC; Montero D
Hum Vaccin Immunother; 2015; 11(3):584-600. PubMed ID: 25715048
[TBL] [Abstract][Full Text] [Related]
31. Reverse Vaccinology and Its Applications.
Kanampalliwar AM
Methods Mol Biol; 2020; 2131():1-16. PubMed ID: 32162247
[TBL] [Abstract][Full Text] [Related]
32. Vaccinology: past achievements, present roadblocks and future promises.
André FE
Vaccine; 2003 Jan; 21(7-8):593-5. PubMed ID: 12531323
[TBL] [Abstract][Full Text] [Related]
33. Designing the next generation of vaccines for global public health.
Bagnoli F; Baudner B; Mishra RP; Bartolini E; Fiaschi L; Mariotti P; Nardi-Dei V; Boucher P; Rappuoli R
OMICS; 2011 Sep; 15(9):545-66. PubMed ID: 21682594
[TBL] [Abstract][Full Text] [Related]
34. Present and future of veterinary viral vaccinology: a review.
van Oirschot JT
Vet Q; 2001 Jul; 23(3):100-8. PubMed ID: 11513250
[TBL] [Abstract][Full Text] [Related]
35. An overview of
Kardani K; Bolhassani A; Namvar A
Expert Rev Vaccines; 2020 Aug; 19(8):699-726. PubMed ID: 32648830
[TBL] [Abstract][Full Text] [Related]
36. Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis.
Viktorova EG; Khattar SK; Kouiavskaia D; Laassri M; Zagorodnyaya T; Dragunsky E; Samal S; Chumakov K; Belov GA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925653
[TBL] [Abstract][Full Text] [Related]
37. Modern biotechnological strategies for vaccine development in aquaculture - Prospects and challenges.
Jose Priya TA; Kappalli S
Vaccine; 2022 Sep; 40(41):5873-5881. PubMed ID: 36088192
[TBL] [Abstract][Full Text] [Related]
38. Platforms, advances, and technical challenges in virus-like particles-based vaccines.
Gupta R; Arora K; Roy SS; Joseph A; Rastogi R; Arora NM; Kundu PK
Front Immunol; 2023; 14():1123805. PubMed ID: 36845125
[TBL] [Abstract][Full Text] [Related]
39. Post-genomic platform for development of oligonucleotide vaccines against RNA viruses: diamond cuts diamond.
Oberemok VV; Andreeva OA; Laikova KV; Novikov IA; Kubyshkin AV
Inflamm Res; 2022 Aug; 71(7-8):729-739. PubMed ID: 35523969
[TBL] [Abstract][Full Text] [Related]
40. [Vaccine of the future].
Lelièvre JD
Rev Francoph Lab; 2019 May; 2019(512):52-63. PubMed ID: 32518603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
